Home » Oculocare’s Alleye App Cleared for Monitoring AMD
Oculocare’s Alleye App Cleared for Monitoring AMD
Oculocare’s Alleye, a mobile application was granted 510(k) clearance by the FDA for monitoring eyesight in age-related macular degeneration (AMD).
The app gives patients the ability to regularly test their eyesight and assess the progression of disease without the supervision of a doctor.
It is designed to detect and characterize visual distortion in patients with macular conditions such as AMD and diabetic retinopathy.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May